The purpose of the study was to evaluate signal-fat-fraction (SFF)-analysis based on a 2-point-Dixon water-fat separation method in whole-body simultaneous PET/MRI for identifying brown adipose tissue (BAT) and discriminating it from white adipose tissue (WAT) using cross-validation via PET.
INTRODUCTION
Brown adipose tissue (BAT) is an organ responsible for thermogenesis through consummation of fat in response to certain stimuli such as low temperatures (1, 2). BAT can be mostly found in supraclavicular and cervical depots in humans, while more anatomical sites (e.g., suprarenal, mediastinal) have been described in post-mortem studies (3).
On a cellular level, in comparison to white adipose tissue (WAT), BAT is an extensively vascularized tissue characterized by smaller adipocytes than those in WAT, containing a centrally located nucleus, multiple triglyceride droplets and a vast amount of ironcontaining mitochondria and intracellular water (4) . BAT can be found predominantly in babies and children, but several studies published during the last years have demonstrated metabolically active BAT in adults (5) (6) (7) . This corroborates observations of the aforementioned post-mortem study that, even though there is an age relationship with BAT distribution, BAT is still present in adults (3) . Notably, there is evidence that adults exhibit two types of BAT, having the same cell morphology but originating from different progenitors (8) .
Prevalence of obesity and its comorbidities is growing worldwide, leading to a global health issue and socioeconomic problem (9) . Different studies have investigated BAT recruitment as a therapeutic approach for obesity, elevated triglyceride concentrations and type 2 diabetes in rodents (10) (11) (12) (13) . Furthermore, studies in adults, pediatrics and adolescents showed an inverse correlation between obesity and the presence of metabolically active BAT determined by 18F-FDG PET/CT examinations (6, 14, 15) , rendering BAT an increasingly relevant role in the fight against obesity in humans ( [16] [17] [18] . The development of precise and reliable tools for the quantification of body fat, its by on August 15, 2017. For personal use only. jnm.snmjournals.org Downloaded from distribution and determination of its type are highly needed. Several recent studies have investigated 18F-FDG PET for identification of BAT making PET/CT a reference modality in BAT imaging (7, 14, 19, 20) in particular as it is depicting metabolic activity of BAT depots. Nevertheless, magnetic resonance imaging (MRI) is currently thought of as the best tool in the evaluation of body fat due to its detailed soft tissue characterization, superior spatial resolution and the lack of exposing the patient to ionizing radiation (21, 22) . Therefore, MRI could represent an encouraging alternative to PET/CT to study BAT independently from its metabolic activity, especially in healthy populations.
Common parameters for the detection of BAT by MRI are the signal-fat-fraction (SFF) and the proton-density fat-fraction (PDFF), defined as the ratio of fat signal intensity over the sum of water and fat signal intensities. SFF and PDFF values reflect the different water content in BAT and WAT and have been approved in several studies (23) (24) (25) .
Some studies tried to relate the results of separate 18F-FDG PET/CT and MRI examinations in a small number of patients proven to have metabolically active BAT on earlier 18F-FDG PET/CT (26, 27) , evaluating metabolic activity and signal characteristics on MRI successively. Simultaneous 18F-FDG PET/MRI represents a method to assess metabolic activity and MRI-signal in a single examination without allowing interference e.g. by external factors such as cold exposition in between scans.
The present study is based on the hypothesis 1) that MRI-SFF-analysis is a reproducible imaging modality for detection of human BAT and discrimination from WAT and 2) that the presence of BAT is independent from BAT being metabolically active. A retrospective analysis using data from whole-body simultaneous 18-F-FDG PET/MRI studies in pediatric subjects based on a 2-point-Dixon water-fat separation method was pursued for identifying BAT with MRI and discriminating it from WAT using crossvalidation via PET, choosing elderly subjects as a control group.
MATERIALS AND METHODS

Subjects
In a retrospective study, all pediatric subjects (age ≤ 21 years at time of examination) who underwent 18F-FDG PET/MRI due to oncological diagnoses between September 2011 and April 2014 were retrieved from the institutional database. Institutional review board approved was obtained and all subjects and/or their legal guardians gave informed assent/consent. Exclusion criteria were standard contraindications for MRI examinations.
A total of 66 18F-FDG PET/MRI examinations in 33 subjects were evaluated. Mean age of the pediatric subjects examined was 14.7 years (range 7.4-21.4). The group of pediatric subjects was composed of 9 female individuals (mean age 16.3 years; range 9.5-21.4) and 24 male individuals (mean age 14.1 years, range 7.4-19.2 years) ( Figure   1 ). As control group, 18F-FDG PET/MRI data from 11 elderly subjects (7 male, 4 female; mean age 79.9 years, range 76.3-88.6) were evaluated. Exclusion criteria again were standard contraindications for MRI examinations. The mean injected activity of 18F-FDG was 254 MBq (SD 97, range 75-471). Subjects fasted 6h before tracer injection, and blood glucose levels were measured just before injection, with a cut-off of 150 mg/dL. Sedation, which could potentially influence BAT activity (28) was not used in any patients.
Whole-body simultaneous 18F-FDG PET/MRI
All examinations were performed on a fully integrated whole-body hybrid system (Biograph mMR; Siemens Healthcare, Erlangen, Germany). 18F-FDG PET/MRI was acquired at a mean of 105 min after tracer injection (range 63-175).
For all 18F-FDG PET/MRI examinations, the following protocol was used. First, MRI localizer sequences were acquired to determine the location and number of PET bed positions. Secondly, the PET emission scans were initiated, with an emission time of 4 min per bed position. A 2-point T1-weighted coronal 3-dimensional Dixon spoiled gradient-echo sequence (VIBE Dixon sequence) combined with a water-fat separation method was acquired for attenuation correction purposes simultaneously at the beginning of every PET measurement. To minimize motion artifacts from incomplete breath-holds, a centric k-space acquisition was used. Imaging parameters and setup for the spoiled gradient-echo sequence are summarized in Table 1 . A water-fat separation was performed based on the raw images yielding four different image series: a) inphase, b) opposed-phase, c) water-weighted and d) fat-weighted. Depending on their oncological diagnosis further MRI-sequences including at least a coronal T1 weighted TSE sequence in all patients were acquired. All images were uploaded to a dedicated workstation (Syngo MMWP, Siemens Healthcare).
Image Analysis
Image datasets were analyzed by 2 experienced readers in consensus (2 years and 8 years) who were blinded to the patients´ history.
In order to identify regions of BAT, the supraclavicular/cervical region was examined, since areas of adipose tissue can be easily identified and delineated in this area on anatomical images and BAT in this region has been broadly characterized in PET/CT and autopsy studies (2, 3, 7, 20) . For areas of WAT, gluteal fat depots were evaluated since they are definable in every patient and it is expected to find exclusively WAT in this region (3, 29) .
For every dataset with 18F-FDG-avid supraclavicular fat depots, regions of interest (ROIs) were placed in the PET-dataset bilaterally into the supraclavicular fat depots, automatically delineating the shape of the 18F-FDG-avid fat depots (50% isocontour). If no or only low 18F-FDG-uptake could be detected, ROIs were placed into the fatweighted MR-image, automatically delineating the region with high signal on fatweighted images-i.e. the fat depot itself. For measurement of WAT, round ROIs were placed into gluteal subcutaneous fat depots bilaterally on the fat-weighted image.
The ROIs were automatically transferred to the co-registered images (fat-weighted and water-weighted images/water-weighted and PET-images respectively). Mean signal intensities on fat-and water-weighted images as well as mean SUVmean of the PETdataset were noted. Signal-fat-fraction (SFF) for BAT and WAT was calculated using the following formula:
fat signal intensity (fat signal intensity + water signal intensity) .
Finally, subjects were divided into two groups: the PET-positive group with moderate to high 18F-FDG-uptake (SUVmean>1) in at least one 18F-FDG PET examination and the PET-negative group with no or low uptake in all available examinations.
Statistical Analysis
Data are expressed as mean (SD, range) if not otherwise denoted. 
RESULTS
First, the numbers of PET-positive and PET-negative subjects were determined. Of the 33 examined pediatric subjects, 16 were found to have 18F-FDG-avid, metabolically active supraclavicular/cervical fat depots in at least one of their examinations suggestive of brown adipose tissue. Therefore these subjects were determined as PET-positive. Of those 16 subjects, 12 had multiple examinations, resulting in a total number of 38 examinations. In all other pediatric subjects (n=17, total number of 28 examinations) and the 11 subjects in the control group, no metabolically active adipose tissue was found (Figure 1) . Thus, these subjects were determined as PET-negative.
Within the group of PET-positive pediatric subjects, MRI-based mean SFF was 0.70 in supraclavicular BAT (SD 0.08, range 0.5-0.88) and 0.92 in gluteal WAT (SD 0.04, range 0.84-0.97). This resulted in a highly significant difference between the two types of fat (p<0.0001) ( Table 2 ).
In the 12 PET-positive subjects with multiple examinations, intraindividual SFF in supraclavicular fat depots was relatively constant at all measurements with a median percentage change of 5% (range 0-39%). In contrast, intraindividual changes in 18F- observed between pediatric and control subjects (p=0.13). Remarkably, the range of the supraclavicular SFF in the control group was comparable to that of gluteal fat depots in the pediatric group (Figure 3 ).
DISCUSSION
The results of the study indicate that 1) SFF determined by the 2-point VIBE Dixon sequence is lower in BAT compared to WAT in children and 2) SFF is independent from the metabolic activity of the tissue as determined by 18F-FDG PET. Thus SFF represents a robust parameter for the identification of BAT, suggesting that BAT can be identified by using MRI only.
The results of the present study suggest that using a 2-point Dixon water-fat separation method, mean SFF in pediatric subjects is significantly lower in supraclavicular/cervical (brown) fat depots compared to gluteal subcutaneous (white) fat depots. This finding confirms that MRI using the described Dixon-method is able to distinguish between these types of adipose tissue based on the higher water content of BAT ( In the control group composed of elderly subjects (≥76 years), supraclavicular SFF values were substantially higher than in the pediatric group, with ranges comparable to that in gluteal fat depots in both pediatric and elderly subjects ( Figure 3 ). Histologically, BAT was never shown to be present in gluteal fat (3, 29) , so it can be hypothesized that both the pediatric and control group had WAT in gluteal fat depots. Consequently, the supraclavicular SFF range in the control group also points to WAT.
The reason for the statistical significant difference between supraclavicular and gluteal SFF in the control group is not completely clear. With regard to the range of supraclavicular and gluteal SFF in this population (Figure 3 ) a broad overlap is present.
It could be hypothesized that a minimal amount of BAT is still present in the supraclavicular region of elderly people leading to a small but statistical significant drop of SSF. However, no histomorphological data are available at the present.
With regard to the longitudinal analysis of SFF compared to 18F-FDG PET, another crucial result of this study was that metabolic activity as determined by PET-based SUVanalysis showed no correlation with SFF in subjects with metabolically active BAT. So far, it was not clear whether BAT is subject to short-term changes in metabolic activity ("sleeping" BAT) depending on factors like nutritional status and environmental conditions (e.g., cold stimulation), or whether the human adipose organ is "plastic", comparable to that of rodents where adipocytes in BAT and WAT populations can reversibly turn into one another as short-term reaction to stimuli such as cold exposure (4, 32, 33) .
Using 18F-FDG PET/CT the detection of BAT is limited to the evidence of metabolic activity by a positive 18F-FDG-uptake in PET with no further tissue characterization being possible. Thus, for tissue characterization in longitudinal studies with PET/CT, histology samples would be required, ideally sampled shortly after the PET/CT examination to avoid distortion by possible short-term plasticity of the adipose organ.
By using PET/MRI in the present study, it was possible to perform simultaneous measurements of metabolic activity as determined by SUVmean and of accurately colocalized tissue composition as determined by SFF not being influenced by a potential change in the metabolic status and composition of BAT using sequential examinations.
In subjects with multiple examinations, intraindividual SUVmean fluctuated massively with a median change of 91% while intraindividual SFF was subject to only minor variations with a median change of 5% (Figure 2 ).This indicates that the composition of the adipose tissue as determined by calculation of SFF stays relatively stable independent from the current metabolic activity (see example: Figure 4 ). Consequently our data argue against the hypothesis of BAT being a "plastic" tissue and is in favor of its constant existence with only a different grade of metabolic activity. However the hypothesis has to be proven in further studies. Hereby, the present data suggest that BAT being not detectable on PET-images due to its metabolic inactivity can potentially be identified using SFF-analysis.
The present study has some limitations. First, BAT can occur in mixed clusters with white adipocytes in humans (4, 33) , thus a certain SFF range is only suggestive of the presence of BAT as it is an average value of the SFF within one fat depot. Furthermore, partial volume effects have to be considered, especially when low resolution PET data are used for setting the ROI, as SFF cannot differentiate between intracellular water content and non-lipid tissue portions (e.g. from vessels) within a voxel.
Second, SFF is not as accurate as the so called proton density fat fraction (PDFF). SFF refers to MR signal attributable to fat and is confounded by various MRI related properties such as T1 or T2*, thus values can differ when changing acquisition parameters, while PDFF refers to the fraction of mobile protons attributable to fat and removes biases such as T1 and T2*, and is potentially more accurate since it uses multipeak fat spectral fitting (25) . Water-fat separation methods applied on six-echo gradient echo data can extract PDFF and are thereby free of any confounding effects (31).
Nevertheless, SFF based on a water-fat separation methods applied on two-echo gradient echo data is a promising tool to verify the presence of BAT without radiation exposure as in PET. Thus compared to PET, SFF and PDFF are more suited as a screening method for detecting BAT or as a method for longitudinal of fat distribution.
Third, the present study was limited by the predominantly male study population (n=24) which was not intentional. Previous PET/CT studies provide conflicting information about gender dependence of BAT in pediatric cohorts (15, 20) and further investigations should also determine gender effects on presence and development of BAT.
Fourth, histology was not used as gold standard diagnostic reference in differentiating WAT from BAT due to ethical and practical reasons. However, 18-FDG-uptake is evidently related to metabolically active BAT (5, 34) . Furthermore, supraclavicular SFF in PET-positive and PET-negative pediatric patients were comparable and in both groups significantly different from gluteal subcutaneous WAT, which in turn was comparable to the supraclavicular and gluteal fat in the control subjects. Considering this together with results from autopsy studies (3) it can be assumed that BAT is present within the supraclavicular/cervical adipose tissue in pediatric subjects and the different adipose tissue in pediatric subjects (gluteal) and elderly subjects (supraclavicular and gluteal) is WAT. • * Fat-saturation techniques with Dixon require 2 repetition times.
• TR/TE = repetition time/echo time; iPAT = integrated parallel acquisition technique.
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